A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2004
12/23/2004	US20040258647 Active ingredient-containing cosmetic cleansing emulsions
12/23/2004	DE202004012410U1 Hardened ethereal oils, useful for medicinal, aroma therapy, cosmetic and pharmaceutical purposes, contain oil of oregano, trilobate sage and/or bay leaves diluted with at least equal amount of lanolin and/or shea butter
12/23/2004	DE10324997A1 Mrp8/Mrp14 Inhibitoren und ihre Verwendung zur Prävention und/oder Behandlung von hypertrophen Narben und Keloiden MRP8 / MRP14 inhibitors and their use for the prevention and / or treatment of hypertrophic scars and keloids
12/23/2004	DE10324256A1 Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung Lipid Tranferprotein systems and their cosmetic / dermatological use
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2526041A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/22/2004	EP1489186A1 Angiogenesis inhibitors
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489179A1 Antiopoietin-related growth factor
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1488810A1 Percutaneous absorption promoters and compositions for treating athlete's foot
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488797A2 Oral preprations having itching-relievign or antipruritic activity
12/22/2004	EP1488776A1 Phenylacetonitrile derivatives and hair tonics and external preparations for skin containing the derivatives
12/22/2004	EP1487876A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487508A1 Therapeutic compositions comprising modified polysaccharides
12/22/2004	EP1487507A1 Wound dressing materials comprising chemically modified polysaccharides
12/22/2004	EP1487506A2 Preparation for wound healing and prevention of bandage adhesion to the wound
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487475A1 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase iv activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487453A1 N- [(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl -2- 3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487408A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
12/22/2004	EP1487404A1 Use of compatible solutes for inhibiting the release of ceramides
12/22/2004	EP1487402A1 New composition including a pigment assembly comprising a mica core
12/22/2004	EP1487273A1 Compositions and methods for treatment of microbial infections
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1480936A4 Process for the preparation of acitretin
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1373264B1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
12/22/2004	EP1363656B1 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1280766B1 Biocidal polymers based on guanidine salts
12/22/2004	EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP1119344B1 Method for prevention and/or cosmetic treatment of skin stripe and use in dermatology
12/22/2004	EP0746294B1 Absorption enhancers for topical pharmaceutical formulations
12/22/2004	EP0732928B1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556711A Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
12/22/2004	CN1556704A Local use medicinal composition
12/22/2004	CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors
12/22/2004	CN1556693A Medicine for preventing and treating bromidrosis
12/22/2004	CN1556087A Preparation method of high purity alkannaphtha quinone
12/22/2004	CN1555863A Chinese medicine for treating keloid
12/22/2004	CN1555861A Chinese medicine oral liquid for treating white patch wind
12/22/2004	CN1555852A External compress Chinese medicinal composition for treating psora and its preparation method
12/22/2004	CN1555847A Medicne for preventing and treating virus and its preparaton method
12/22/2004	CN1555846A Psoriasis quick convalescence essence
12/22/2004	CN1555845A Cell revival agent
12/22/2004	CN1555837A Chinese medicinal bag for nourishing face and supplementing qi
12/22/2004	CN1555804A Phenasteroid gel preparation
12/22/2004	CN1555802A Cinnarizone self micro emulsified soft capsule and its preparation method
12/22/2004	CN1555779A External use liquid for stopping sweat
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1180844C Antipruritic agent
12/22/2004	CN1180833C Chinese medicine preparation for treating skin and external diseases
12/22/2004	CN1180825C Itch-stopping bactericidal medicine and its prepn process
12/22/2004	CN1180817C Body-building fast-acting hair-growing compound instant particles and preparing method thereof
12/22/2004	CN1180809C Alopecia treating tincture and its prepn process
12/22/2004	CN1180805C Medicine for curing burn and scald and its production method
12/22/2004	CN1180804C Sore healing powder and preparing process
12/22/2004	CN1180796C Process for preparing plaster for treating burn
12/22/2004	CN1180795C External use plaster for removing pus and Shengji
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833363 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation

1 ... 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 ... 1065